Novartis AG (BCBA:NVS)

Novartis AG Ratios and Metrics

Market cap in millions ARS. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 19, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	325,498,341	201,761,951	167,490,682	34,441,450	20,230,863	18,083,265
Market Cap Growth	41.77%	20.46%	386.31%	70.24%	11.88%	40.55%
Enterprise Value	359,563,109	219,476,263	178,425,590	36,247,364	23,004,268	20,485,376
Last Close Price	42400.00	28593.43	23307.44	7492.87	4217.64	3244.67
PE Ratio	20.00	16.39	13.95	27.96	8.20	26.64
PS Ratio	4.95	3.78	4.44	4.47	4.48	4.31
PB Ratio	6.49	4.43	4.43	3.27	2.91	3.80
P/TBV Ratio	-	-	-	69.00	21.01	-
P/FCF Ratio	14.13	12.04	15.46	14.60	14.07	17.38
P/OCF Ratio	13.14	11.11	14.33	13.66	13.07	15.75
EV/Sales Ratio	4.97	4.12	4.73	4.71	5.09	4.88
EV/EBITDA Ratio	11.52	10.30	12.60	14.68	14.33	16.32
EV/EBIT Ratio	14.30	13.04	17.46	22.21	20.43	24.00
EV/FCF Ratio	15.61	13.10	16.47	15.36	16.00	19.69
Debt / Equity Ratio	0.78	0.71	0.57	0.47	0.46	0.67
Debt / EBITDA Ratio	1.37	1.50	1.49	1.97	1.95	2.49
Debt / FCF Ratio	1.69	1.93	1.97	2.10	2.22	3.08
Asset Turnover	0.55	0.51	0.43	0.35	0.34	0.41
Inventory Turnover	2.17	2.20	1.84	1.67	1.65	2.31
Quick Ratio	0.50	0.79	0.88	1.00	1.25	0.65
Current Ratio	0.82	1.03	1.16	1.29	1.51	0.90
Return on Equity (ROE)	32.49%	26.27%	16.15%	9.51%	36.80%	14.38%
Return on Assets (ROA)	11.88%	10.09%	7.27%	4.62%	5.28%	5.16%
Return on Capital (ROIC)	16.47%	13.72%	9.84%	6.18%	7.08%	7.07%
Return on Capital Employed (ROCE)	26.40%	22.20%	17.20%	10.40%	10.80%	10.70%
Earnings Yield	5.00%	6.10%	7.17%	3.58%	12.19%	3.75%
FCF Yield	7.07%	8.30%	6.47%	6.85%	7.11%	5.75%
Dividend Yield	1.51%	13.93%	13.59%	8.18%	8.28%	8.79%
Payout Ratio	57.26%	63.85%	48.85%	107.92%	30.67%	86.56%
Buyback Yield / Dilution	3.37%	2.73%	4.78%	2.79%	1.57%	0.99%
Total Shareholder Return	4.88%	16.65%	18.37%	10.97%	9.85%	9.78%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.